FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

929360031000036100: Trade product unit of use reference set (foundation metadata concept)


Status: current, Primitive. Date: 31-Mar 2011. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
3288241000168117 TPUU (trade product unit of use) reference set en Synonym Active Case sensitive Australian Medicines Terminology module
965507211000036117 Trade product unit of use reference set en Synonym Active Case sensitive Australian Medicines Terminology module
965507221000036112 Trade product unit of use reference set (foundation metadata concept) en Fully specified name Active Case sensitive Australian Medicines Terminology module
4351521000168116 <p>Terminology to describe in a health record a single dose unit of a finished dose form that contains a specified amount of an active ingredient substance and is grouped within a particular Trade Product.</p><p>This reference set supports the accurate and unambiguous electronic communication and exchange of medicines information between clinicians for medication management and the recording of adverse reactions.</p><p><b>Target client: </b>NCTS</p> en Definition Active Case sensitive Australian Medicines Terminology module


21787 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Trade product unit of use reference set Has licence SNOMED CT-AU licence​ true Inferred relationship Some 1608248233
Trade product unit of use reference set Developed by Australian Digital Health Agency true Inferred relationship Some 859287708
Trade product unit of use reference set Is a Simple type reference set true Inferred relationship Some

Members
Buvidal Monthly 128 mg/0.36 mL modified release injection, 0.36 mL syringe
Buvidal Monthly 160 mg/0.45 mL modified release injection, 0.45 mL syringe
Buvidal Monthly 64 mg/0.18 mL modified release injection, 0.18 mL syringe
Buvidal Monthly 96 mg/0.27 mL modified release injection, 0.27 mL syringe
Buvidal Weekly 16 mg/0.32 mL modified release injection, 0.32 mL syringe
Buvidal Weekly 24 mg/0.48 mL modified release injection, 0.48 mL syringe
Buvidal Weekly 32 mg/0.64 mL modified release injection, 0.64 mL syringe
Buvidal Weekly 8 mg/0.16 mL modified release injection, 0.16 mL syringe
Bydureon (exenatide 2 mg) modified release injection, 2 mg chamber
Bydureon (exenatide 2 mg) modified release injection, 2 mg vial
Bydureon (inert substance) diluent, chamber
Bydureon (inert substance) diluent, syringe
Bydureon BCise 2 mg/0.85 mL modified release injection, 2 mL pen device
Byetta (exenatide 10 microgram / 0.04 mL) injection, 2.4 mL pen device (trade product unit of use)
Byetta 5 microgram/0.02 mL injection, 1.2 mL pen device
C Plus (Nutrition Care) powder for oral liquid
C Plus (Nutrition Care) tablet
C-Flox 250 mg tablet
C-Flox 500 mg tablet
C-Flox 750 mg tablet
C-Zine (Amcal) 10 mg tablet
C-Zine (Chemists' Own) 10 mg tablet
C-Zine (Guardian) 10 mg tablet
C20 (Cannatrek) oral oil
CAPD/DPCA 17 Sleep Safe peritoneal dialysis solution, 6 L bag
CAPD/DPCA 17 Sleep Safe peritoneal dialysis solution, 3 L bag
CAPD/DPCA 17 Sleep Safe peritoneal dialysis solution, 5 L bag
CBD (Satipharm) 50 mg capsule
CDA CBD 240 mg/mL oral oil
CDA CBD 30 mg/mL oral oil
CDA CBD 33.33 mg capsule
CMV Immunoglobulin-VF (CSL) 1.5 million unit/30 mL injection, 30 mL vial
CT Plus + 2.2% liquid
Cabaser 1 mg tablet
Cabaser 2 mg tablet
Cabaser 4 mg tablet
Cabazitaxel (Accord) 60 mg/3 mL injection, 3 mL vial
Cabazitaxel (Ever Pharma) 45 mg/4.5 mL injection, 4.5 mL vial
Cabazitaxel (Ever Pharma) 60 mg/6 mL injection, 6 mL vial
Cabazitaxel (Juno) (cabazitaxel 60 mg/1.5 mL) injection, 1.5 mL vial
Cabazitaxel (Juno) (inert substance) diluent, 4.5 mL vial
Cabazitaxel (MSN) (cabazitaxel 60 mg/1.5 mL) injection, 1.5 mL vial
Cabazitaxel (MSN) (inert substance) diluent, 4.5 mL vial
Cabazitaxel (Sanofi) (cabazitaxel 60 mg/1.5 mL) injection, 1.5 mL vial
Cabazitaxel (Sanofi) (inert substance) diluent, 4.5 mL vial
Cabazitaxel (Winthrop) (cabazitaxel 60 mg/1.5 mL) injection, 1.5 mL vial
Cabazitaxel (Winthrop) (inert substance) diluent, 4.5 mL vial
Cabenuva Cabotegravir 400 mg/2 mL modified release injection, 2 mL vial
Cabenuva Cabotegravir 600 mg/3 mL modified release injection, 3 mL vial
Cabenuva Rilpivirine 600 mg/2 mL modified release injection, 2 mL vial
Cabenuva Rilpivirine 900 mg/3 mL modified release injection, 3 mL vial
Cabergoline (Apo) (cabergoline 500 microgram) tablet (trade product unit of use)
Cabergoline (Apotex) 500 microgram tablet
Cabergoline (GenRx) 500 microgram tablet
Cablivi (caplacizumab 10 mg) powder for injection, 10 mg vial
Cablivi (inert substance) diluent, 1 mL syringe
Cabometyx 20 mg tablet
Cabometyx 40 mg tablet
Cabometyx 60 mg tablet
Cadatin 10/10 tablet
Cadatin 10/20 tablet
Cadatin 10/40 tablet
Cadatin 10/80 tablet
Cadatin 5/10 tablet
Cadatin 5/20 tablet
Cadatin 5/40 tablet
Cadatin 5/80 tablet
Cadivast 10/10 tablet
Cadivast 10/20 tablet
Cadivast 10/40 tablet
Cadivast 10/80 tablet
Cadivast 5/10 tablet
Cadivast 5/20 tablet
Cadivast 5/40 tablet
Cadivast 5/80 tablet
Caduet 10/10 tablet
Caduet 10/20 tablet
Caduet 10/40 tablet
Caduet 10/80 tablet
Caduet 5/10 tablet
Caduet 5/20 tablet
Caduet 5/40 tablet
Caduet 5/80 tablet
Caelyx 20 mg/10 mL injection, 10 mL vial
Caelyx 50 mg/25 mL injection, 25 mL vial
Cafergot tablet
Cafergot S suppository
Cafex 100 mg tablet
Cafnea 25 mg/5 mL oral liquid, 5 mL
Cafnea 40 mg/2 mL injection, 2 mL vial
Cal Sup 1.25 g (calcium 500 mg) tablet
Cal-500 1.25 g (calcium 500 mg) chewable tablet
Cal-600 1.5 g (calcium 600 mg) tablet
Cal-600 plus D tablet
Cal-Care 1.5 g (calcium 600 mg) tablet
Calamari Gold (Bioglan) 1 g capsule
Calamine (David Craig) lotion
Calamine (Faulding) lotion
Calamine (Gold Cross) 15% lotion
Calamine (Orion) 15% lotion
Calamine (PharmAust Manufacturing) 15% lotion

Start Previous Page 32 of 218 Next End


Reference Sets

Reference set descriptor

Back to Start